$ETST’s President, Director, & COO concludes wit

$ETST’s President, Director, & COO concludes with, “Gabriel has done a remarkable job building our sales team and expanding our presence across the U.S. I have no doubt that 2018 is going to be a solid year of growth for us, with all we have initiating as early as January alone, with our CBD products. Our MSN-2 medical device globalization strategy is still on track, and we are currently in talks with institutional investors thanks to our planned up-listing in Q1 2018. I plan on sharing further updates as they progress on the MSN-Medical device, IP patents, CBD based pharmaceutical generic drugs, and our new CBD formula opioid clinical trials as they progress.”

Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!